Goodrich Katherine
- SEC CIK
- 0002044770
In the past year, 1 open-market sale filing worth $183.4K and no purchases.
Current role at each company
- TARS Tarsus Pharmaceuticals, Inc.Directoras of Jun 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $183.4K
- 1 filing
- Net
- −$183.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Goodrich Katherine as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Goodrich KatherineDirector | SSale | −2.95K | $62.08 | −$183.4K | −57.0%2.23K after | 10b5-1 |